Your browser doesn't support javascript.
loading
Does three cycles of neoadjuvant chemotherapy prior to concurrent chemoradiotherapy provide benefits for all childhood patients with locoregionally advanced nasopharyngeal carcinoma?
Jin, Ya-Nan; Cao, Hui-Jiao; Gong, Xiao-Hua; Zhang, Wang-Jian; Marks, Tia; Yao, Ji-Jin; Xia, Liang-Ping.
Afiliación
  • Jin YN; VIP Region, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong Province, China.
  • Cao HJ; State Key Laboratory of Oncology in South China, Guangzhou, Guangdong Province, China.
  • Gong XH; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong Province, China.
  • Zhang WJ; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, China.
  • Marks T; VIP Region, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong Province, China.
  • Yao JJ; The Cancer Center of the Fifth Affiliated Hospital of Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Biomedical Imaging, Zhuhai, Guangdong Province, China.
  • Xia LP; Department of Medical Statistics, School of Public Health, Sun Yat-Sen University, Guangzhou, Guangdong Province, China.
J Cancer Res Clin Oncol ; 148(10): 2569-2579, 2022 Oct.
Article en En | MEDLINE | ID: mdl-34618220
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Nasofaríngeas / Infecciones por Virus de Epstein-Barr Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adolescent / Child / Humans Idioma: En Revista: J Cancer Res Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Nasofaríngeas / Infecciones por Virus de Epstein-Barr Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Adolescent / Child / Humans Idioma: En Revista: J Cancer Res Clin Oncol Año: 2022 Tipo del documento: Article País de afiliación: China